A Dose Ranging Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of Lamivudine in Children and Adolescents with Chronic Hepatitis B

Fifty-three patients with chronic hepatitis B and active viral replication were studied for 4 weeks while on treatment and for 12 weeks after treatment with the oral nucleoside analogue lamivudine. Children aged 2 to 12 years were randomized to receive twice-daily doses of 0.35, 1.5, or 4 mg of lami...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Sokal, Etienne M., Roberts, Eve A., Mieli-Vergani, Giorgina, McPhillips, Penny, Johnson, Mark, Barber, Judy, Dallow, Nigel, Boxall, Elizabeth, Kelly, Deirdre
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2000
Gaiak:	Antiviral Agents
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89731/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10681323/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.3.590-597.2000
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!